NAcM-OPT is a specific, reversible and orally bioavailable inhibitor of cullin neddylation 1 (DCN1) that targets N-Acetyl-UBE2M (E2 conjugating enzyme, UBC12) interaction with DCN1 with IC50 of 79 nM.
[1] Daniel C Scott, et al. Nat Chem Biol. 2017 Aug;13(8):850-857.
















